Table 2.
Parameters | eGFR | Multiple linear regression | ||
---|---|---|---|---|
Adjust R | P | β | P | |
Age | −0.172 | 0.029* | −0.504 | 0.020* |
Female gender | 0.167 | 0.035* | 9.259 | 0.045* |
Hypertension | −0.182 | 0.021* | −10.497 | 0.018* |
Polycystic liver | 0.041 | 0.601 | ||
Leukocyte | −0.037 | 0.643 | ||
Thrombocyte | 0.261 | 0.001** | 0.084 | 0.005* |
Hemoglobin | 0.547 | <0.001** | 0.823 | <0.001** |
Albumin | 0.052 | 0.507 | ||
Globulin | −0.138 | 0.080 | ||
Related symptoms | 0.082 | 0.305 |
Correlations between eGFR and major clinical parameters were assessed by Spearman rho test and adjusted by partial correlation analysis. Multiple linear regression was performed to validate these identified parameters.
P<0.05;
P<0.01.